Russia to Sell 100 Mln Doses of COVID-19 Vaccine to Indian Pharmaceutical Company

russia-to-sell-100-mln-doses-of-covid-19-vaccine-to-indian-pharmaceutical-company

World

Get short URL

https://cdn1.img.sputniknews.com/img/07e4/09/0c/1080442302_0:0:3072:1729_1200x675_80_0_0_b8b479e56a41d47aff5ee99a6083851f.jpg

Sputnik International

https://cdn2.img.sputniknews.com/i/logo.png

https://sputniknews.com/world/202009161080472568-russia-to-sell-100-mln-doses-of-covid-19-vaccine-to-indian-pharmaceutical-company/

In August, Russia registered the world’s first COVID-19 vaccine, named Sputnik V and developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology. The vaccine is yet to complete the required Phase 3 of clinical trials.

The Russian Direct Investment Fund, one of the developers of Russia’s Sputnik V, has agreed to deliver 100 million doses of the vaccine to Dr. Reddy’s Laboratories, a pharmaceutical company in India, the fund said in a statement.

Russia registered the world’s first COVID-19 vaccine, named Sputnik V and developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, on 11 August, announcing that it will hold the Phase 3 trials involving around 2,000 people. The Russian Ministry of Health has said that Sputnik V underwent all the necessary checks and was proven to be capable of building immunity against the virus.st.


©
Photo : press service of the Russian Health Ministry

Russia Coronavirus Vaccine

Another two domestic and two foreign vaccines are at the registration stage in Russia. The vaccines in question are those developed by Vector, the Chumakov Federal Scientific Centre for Research and Development of Immune and Biological Products, China’s Sinopharm and British-Swedish multinational AstraZeneca.

administrator

    Related Articles